MB Renal Program still uses unfractionated heparin for in-centre HD. We lock catheters with heparin 1,000 units/mL (not 4% citrate, not heparin 5.000 u/mL) so it’s not been cost-effective to switch to LMWH.
We do currently use dalteparin in Home HD patients using the NxStage machine and did previously use tinzaparin.
Are there biosimilar LMWHs coming out? Which ones?
Lori Wazny, Pharm.D.